Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Jolimoy

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Presse Medicale (Paris, France : 1983)|October 25, 2003
[Identification of drug misuse. Study of spontaneous notifications of adverse drug events in a regional safety reporting centre]C Livry, A Disson-Dautriche, G Jolimoy, et al.
Bulletin Du Cancer|March 6, 1999
[Neoadjuvant chemotherapy FEC-HD in locally advanced breast cancer]A Darut-Jouve, B Coudert, G Jolimoy, et al.
Annales De Dermatologie Et De Venereologie|March 29, 2007
[Infliximab-induced skin reaction with visceral manifestations and high levels of anti-DNA antibodies]G Jeudy, Y Dutronc, C Galliot-Repkat, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 26, 1999
Nitric oxide synthase in human breast cancer is associated with tumor grade, proliferation rate, and expression of progesterone receptorsS Reveneau, L Arnould, G Jolimoy, et al.
British Journal of Cancer|September 1, 1996
Hypodiploidy, Ki-67 growth fraction and prognosis of surgically resected lung cancersJ L Pujol, J Simony, G Jolimoy, et al.
Revue Des Maladies Respiratoires|August 5, 1998
[Biological perspectives]J L Pujol, P Demoly, X Quantin, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Presse Medicale (Paris, France : 1983)|October 25, 2003
[Identification of drug misuse. Study of spontaneous notifications of adverse drug events in a regional safety reporting centre]C Livry, A Disson-Dautriche, G Jolimoy, et al.
Bulletin Du Cancer|March 6, 1999
[Neoadjuvant chemotherapy FEC-HD in locally advanced breast cancer]A Darut-Jouve, B Coudert, G Jolimoy, et al.
Annales De Dermatologie Et De Venereologie|March 29, 2007
[Infliximab-induced skin reaction with visceral manifestations and high levels of anti-DNA antibodies]G Jeudy, Y Dutronc, C Galliot-Repkat, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 26, 1999
Nitric oxide synthase in human breast cancer is associated with tumor grade, proliferation rate, and expression of progesterone receptorsS Reveneau, L Arnould, G Jolimoy, et al.
British Journal of Cancer|September 1, 1996
Hypodiploidy, Ki-67 growth fraction and prognosis of surgically resected lung cancersJ L Pujol, J Simony, G Jolimoy, et al.
Revue Des Maladies Respiratoires|August 5, 1998
[Biological perspectives]J L Pujol, P Demoly, X Quantin, et al.
Pageof 1